Search company, investor...


Founded Year



Series G | Alive

Total Raised


Last Raised

$52.08M | 4 mos ago

About CureApp

CureApp is a digital health company that offers a horizontal spread of medical apps for the treatment and management of a range of diseases, which allows patient treatment data to be obtained on a daily basis through mobile devices such as smartphones. This information is then analyzed using algorithms based on known medical information in order to provide personalized guidance for individual patients. Its apps exhibit therapeutic effects against nicotine addiction, NASH (non-alcoholic steatohepatitis remedy), diabetes, depression, and lung cancer. The firm serves clients operating in the healthcare sector. It was founded in 2014 and is based in Tokyo, Japan.

Headquarters Location

Kodenmacho YS Building 4F 12-5 Nihonbashikodenmachō, Chūō-ku

Tokyo, 103-0001,


ESPs containing CureApp

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare / Healthcare Payers Tech

The companies in this market develop digital therapeutics to help individuals quit smoking. Startups have developed CBT-backed digital apps to help users reduce cravings and overcome withdrawals and lapses. Some have paired their app with carbon monoxide (CO) monitors that allow smokers to track their progress as they try to quit.

CureApp named as Outperformer among 5 other companies, including Click Therapeutics, Pivot, and 2Morrow.

Compete with CureApp?

Ensure that your company and products are accurately represented on our platform.

CureApp's Products & Differentiators

    Smoking cessesaion

    Lifestyle intervention through a mobile application in combination with a carbon monoxide checker. The app can fill treatment gaps between clinic visits and the CO Checker provides an objective measurement. The app for users contains educational contents, data tracking, and personalized motivational support functions. A healthcare provider can check users' conditions and cessation progress on a web portal. The portal also provides recommendations to the providers aiming to improve overall cessation treatment effectiveness.

Research containing CureApp

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned CureApp in 5 CB Insights research briefs, most recently on Dec 8, 2021.

Expert Collections containing CureApp

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CureApp is included in 7 Expert Collections, including Digital Health.


Digital Health

13,889 items

Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)


Mental Health Tech

1,260 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.


Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Medical Devices

8,560 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.



2,046 items

CureApp Patents

CureApp has filed 1 patent.

The 3 most popular patent topics include:

  • Psychiatric diagnosis
  • Psychotherapy
  • Cognitive behavioral therapy
patents chart

Application Date

Grant Date


Related Topics




Cognitive behavioral therapy, Psychiatric diagnosis, Psychotherapy, Stimulants, Smoking cessation


Application Date


Grant Date



Related Topics

Cognitive behavioral therapy, Psychiatric diagnosis, Psychotherapy, Stimulants, Smoking cessation



Latest CureApp News

CureApp: Digital Therapeutic App for Hypertension Receives Insurance Coverage, Sales of the Service to Me

Nov 2, 2022

Assisting Lifestyle Changes as a Treatment for Hypertension CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) announces the start of insurance coverage for its CureApp HT Hypertension Adjunctive Treatment App (hereafter, CureApp HT), a DTx*1 solution treating hypertension, in Japan from September 1, 2022. Looking ahead, the app will be prescribed and provided to patients with hypertension as a health insurance treatment at medical institutions. This press release features multimedia. View the full release here: AD Assisting Lifestyle Changes as a Treatment for Hypertension (Graphic: Business Wire) After confirming the efficacy and safety of CureApp HT through clinical trials, the results of a Japanese Phase III domestic multicenter randomized controlled trial were published in EHJ, one of the most well-respected peer reviewed journals in the world in 2021. In April 2022, CureApp HT was the first digital therapeutics app for hypertension to receive government approval in the world, and the app has been covered by insurance since September 1. This marks the first case of a DTx treatment solution being covered by insurance in the field of hypertension in the world. Looking ahead, CureApp looks to pursue further commercialization efforts of this Japanese-led medical innovation. The impact of hypertension is seen beyond Japan's borders, and efforts to correct patient lifestyle habits is a common theme across the globe. Therefore, CureApp also plans to proactively expand CureApp HT's reach all over the world, beginning with the U.S.

CureApp Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CureApp Rank

CureApp Frequently Asked Questions (FAQ)

  • When was CureApp founded?

    CureApp was founded in 2014.

  • Where is CureApp's headquarters?

    CureApp's headquarters is located at Kodenmacho YS Building 4F, Tokyo.

  • What is CureApp's latest funding round?

    CureApp's latest funding round is Series G.

  • How much did CureApp raise?

    CureApp raised a total of $90.61M.

  • Who are the investors of CureApp?

    Investors of CureApp include The Carlyle Group, Keio Innovation Initiative, Iwagin Jigyo Souzou Capital, Mizuho Capital, Dai-ichi Life Insurance and 14 more.

  • Who are CureApp's competitors?

    Competitors of CureApp include Quit Genius, Allm, Click Therapeutics, Alex Therapeutics, Pear Therapeutics and 7 more.

  • What products does CureApp offer?

    CureApp's products include Smoking cessesaion and 4 more.

Compare CureApp to Competitors

Click Therapeutics Logo
Click Therapeutics

Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeutics enable change within individuals and are designed to be used independently or in conjunction with biomedical treatments. Click's smoking cessation program is currently available nationwide through a variety of payers, providers, and employers. Click Therapeutics was founded in 2012 and is based in New York, New York.

Kwit Logo

Kwit is a mobile app game that uses cognitive and behavioral therapies and evidence-based smoking cessation scientific methods to help users quit smoking and fight the symptoms of withdrawal.

2Morrow Logo

2Morrow is a digital health/digital therapeutic company focused on behaviors that cause chronic disease. The company delivers programs based on the work of respected researchers directly into the hands of people, whenever and wherever they need them via their smartphone.

Pivot Logo

Pivot is a digital health company on a mission to use mobile technology, behavioral science, and clinical expertise to engage and empower. The company's Pivot combines wearable tech, clinical expertise, personal coaching, and behavioral science to help people quit smoking.

Quit Genius Logo
Quit Genius

Quit Genius develops a digital clinic that delivers a comprehensive Medication-Assisted Treatment program for multiple addictions. It partners with employers, health plans, PBMs, and individual members, to battle addiction in the workplace across the U.S. and the U.K. The company was founded in 2017 and is based in New York, New York.

Alex Therapeutics

Alex Therapeutics is a digital therapeutics (DTx) company that designs and develops Software-as-a-Medical-Devices (SaMDs). With the "Alex DTx Platform" and expertise in artificial intelligence and evidence-based psychology, Alex Therapeutics is positioned to deliver reliable DTx products. The company was founded in 2018 and is based in Stockholm, Sweden.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.